PTGX icon

Protagonist Therapeutics

136 hedge funds and large institutions have $522M invested in Protagonist Therapeutics in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 42 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.4M
Puts
$2.59M
Net Calls
Net Calls Change

Top Sellers

1 -$29.9M
2 -$24.2M
3 -$9.64M
4
RI
RTW Investments
New York
-$6.38M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
-$2.83M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$157K
102
$157K
103
$156K
104
$155K
105
$154K
106
$143K
107
$141K
108
$128K
109
$124K
110
$121K
111
$121K
112
$116K
113
$113K
114
$112K
115
$111K
116
$100K
117
$93.1K
118
$73.1K
119
$69K
120
$64.4K
121
$63K
122
$60K
123
$40.2K
124
$31.9K
125
$22K